Clinical Trial

Clinicopathological Value of p16 Expression in Colorectal Carcinoma

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 10, 2025 (before its estimated March 21, 2026 completion). Its status may not reflect the trial's current state.
Summary
Evaluation of the immunohistochemical expression of p16 in colorectal carcinoma and correlate its expression to different clinical and pathological parameters as patients' ages, sexes, tumor location, histopathological phenotype, status of nodal involvement, perineural and lymphovascular invasion.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Trial Details
NCT Number NCT07047482
Lead Sponsor Sohag University
Conditions Colorectal Carcinoma
Enrollment 50 participants
Start Date 2025-05-01
Primary Completion 2026-03-21 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-10